Role and place of immunotherapy in oropharyngeal cancer by the example of a clinical case

Oropharyngeal cancer is a serious medical and social problem. Risk factors for its development include smoking and alcohol, exposure to harmful chemical factors, as well as chronic inflammation of the corresponding localization, caused, among other things, by the human papillomavirus. The clinical picture of oropharyngeal cancer often imitates infectious diseases, while untimely diagnosis followed by unfavorable outcomes. The presented clinical case lasting more than 12 years demonstrates an adequate approach to the diagnosis and treatment of oropharyngeal cancer. Also, the inclusion of immunotherapy with Nivolumab allowed to achieve stabilization of the oncological process against the background of the development of platinum resistance.